# Relmada Therapeutics, Inc.: Form DEF 14A, filed Dec 15, 2017

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: DEF 14A
- Filed: 2017-12-15
- Accepted by EDGAR: Dec 15, 2017, 16:38 ET
- Period: 2017-12-18
- Accession: 0001213900-17-013299
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390017013299/def14a1117_relmadathera.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390017013299/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390017013299/def14a1117_relmadathera.htm

Filed Dec 15, 2017.
Source: SEC EDGAR, the filing index for accession 0001213900-17-013299. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
